1.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

2.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

3.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

4.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

5.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

6.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

7.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

8.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

9.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

1.

Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study.

2.

Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study.

3.

Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study.

4.

Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study.

5.

Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study.

6.

Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study.

7.

Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study.

8.

Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study.

9.

Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study.

1.

Genetic Variation in RIN3 in the Belgian Population Supports Its Involvement in the Pathogenesis of Paget's Disease of Bone and Modifies the Age of Onset.

2.

Genetic Variation in RIN3 in the Belgian Population Supports Its Involvement in the Pathogenesis of Paget's Disease of Bone and Modifies the Age of Onset.

3.

Genetic Variation in RIN3 in the Belgian Population Supports Its Involvement in the Pathogenesis of Paget's Disease of Bone and Modifies the Age of Onset.

4.

Genetic Variation in RIN3 in the Belgian Population Supports Its Involvement in the Pathogenesis of Paget's Disease of Bone and Modifies the Age of Onset.

5.

Genetic Variation in RIN3 in the Belgian Population Supports Its Involvement in the Pathogenesis of Paget's Disease of Bone and Modifies the Age of Onset.

6.

Genetic Variation in RIN3 in the Belgian Population Supports Its Involvement in the Pathogenesis of Paget's Disease of Bone and Modifies the Age of Onset.

7.

Genetic Variation in RIN3 in the Belgian Population Supports Its Involvement in the Pathogenesis of Paget's Disease of Bone and Modifies the Age of Onset.

8.

Genetic Variation in RIN3 in the Belgian Population Supports Its Involvement in the Pathogenesis of Paget's Disease of Bone and Modifies the Age of Onset.

9.

Genetic Variation in RIN3 in the Belgian Population Supports Its Involvement in the Pathogenesis of Paget's Disease of Bone and Modifies the Age of Onset.

1.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

2.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

3.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

4.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

5.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

6.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

7.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

8.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

9.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

1.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

2.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

3.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

4.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

5.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

6.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

7.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

1.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

2.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

3.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

4.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

5.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

6.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

7.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

8.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

9.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

1.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

2.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

3.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

4.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

5.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

6.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

7.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

8.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

9.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

1.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

2.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

3.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

4.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

5.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

6.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

7.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

8.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

9.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

1.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

2.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

3.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

4.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

5.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

6.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

7.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

8.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

9.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

1.

Epidemiology of multidrug-resistant microorganisms among nursing home residents in Belgium.

2.

Epidemiology of multidrug-resistant microorganisms among nursing home residents in Belgium.

3.

Epidemiology of multidrug-resistant microorganisms among nursing home residents in Belgium.

4.

Epidemiology of multidrug-resistant microorganisms among nursing home residents in Belgium.

5.

Epidemiology of multidrug-resistant microorganisms among nursing home residents in Belgium.